RU96107214A - APPLICATION OF OLIGOSACCHARIDES TO PREVENT OR OR TO FIGHT AGING TISSUE - Google Patents
APPLICATION OF OLIGOSACCHARIDES TO PREVENT OR OR TO FIGHT AGING TISSUEInfo
- Publication number
- RU96107214A RU96107214A RU96107214/14A RU96107214A RU96107214A RU 96107214 A RU96107214 A RU 96107214A RU 96107214/14 A RU96107214/14 A RU 96107214/14A RU 96107214 A RU96107214 A RU 96107214A RU 96107214 A RU96107214 A RU 96107214A
- Authority
- RU
- Russia
- Prior art keywords
- oligoside
- oligosaccharide
- residue
- formula
- hex
- Prior art date
Links
- 229920001542 oligosaccharide Polymers 0.000 title claims 21
- 150000002482 oligosaccharides Polymers 0.000 title claims 21
- 230000032683 aging Effects 0.000 title claims 5
- 210000001519 tissues Anatomy 0.000 title claims 2
- 239000000203 mixture Substances 0.000 claims 10
- GUBGYTABKSRVRQ-UUNJERMWSA-N Lactose Natural products O([C@@H]1[C@H](O)[C@H](O)[C@H](O)O[C@@H]1CO)[C@H]1[C@@H](O)[C@@H](O)[C@H](O)[C@H](CO)O1 GUBGYTABKSRVRQ-UUNJERMWSA-N 0.000 claims 6
- 239000008101 lactose Substances 0.000 claims 6
- 125000004432 carbon atoms Chemical group C* 0.000 claims 5
- GUBGYTABKSRVRQ-XLOQQCSPSA-N lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 claims 5
- XLOMVQKBTHCTTD-UHFFFAOYSA-N zinc monoxide Chemical group [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 claims 5
- WQZGKKKJIJFFOK-PHYPRBDBSA-N α-D-galactose Chemical group OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 claims 5
- 210000002808 Connective Tissue Anatomy 0.000 claims 3
- UQZIYBXSHAGNOE-XNSRJBNMSA-N Stachyose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO[C@@H]2[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO[C@@H]3[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO)O3)O)O2)O)O1 UQZIYBXSHAGNOE-XNSRJBNMSA-N 0.000 claims 3
- UQZIYBXSHAGNOE-USOSMYMVSA-N Stachyose Natural products O(C[C@H]1[C@@H](O)[C@H](O)[C@H](O)[C@@H](O[C@@]2(CO)[C@H](O)[C@@H](O)[C@@H](CO)O2)O1)[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@H](CO[C@@H]2[C@@H](O)[C@@H](O)[C@@H](O)[C@H](CO)O2)O1 UQZIYBXSHAGNOE-USOSMYMVSA-N 0.000 claims 3
- 125000000217 alkyl group Chemical group 0.000 claims 3
- 230000000875 corresponding Effects 0.000 claims 3
- 150000002402 hexoses Chemical class 0.000 claims 3
- 125000001165 hydrophobic group Chemical group 0.000 claims 3
- GZCGUPFRVQAUEE-KCDKBNATSA-N D-(+)-Galactose Natural products OC[C@@H](O)[C@H](O)[C@H](O)[C@@H](O)C=O GZCGUPFRVQAUEE-KCDKBNATSA-N 0.000 claims 2
- FBPFZTCFMRRESA-KVTDHHQDSA-N Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 claims 2
- HEBKCHPVOIAQTA-ZXFHETKHSA-N Ribitol Chemical compound OC[C@H](O)[C@H](O)[C@H](O)CO HEBKCHPVOIAQTA-ZXFHETKHSA-N 0.000 claims 2
- 239000002262 Schiff base Substances 0.000 claims 2
- 150000004753 Schiff bases Chemical class 0.000 claims 2
- 210000003491 Skin Anatomy 0.000 claims 2
- 239000002253 acid Substances 0.000 claims 2
- 125000001931 aliphatic group Chemical group 0.000 claims 2
- 150000003973 alkyl amines Chemical class 0.000 claims 2
- 239000000969 carrier Substances 0.000 claims 2
- 239000002537 cosmetic Substances 0.000 claims 2
- 150000004985 diamines Chemical class 0.000 claims 2
- 150000002338 glycosides Chemical class 0.000 claims 2
- 230000002209 hydrophobic Effects 0.000 claims 2
- 230000003647 oxidation Effects 0.000 claims 2
- 238000007254 oxidation reaction Methods 0.000 claims 2
- 150000002972 pentoses Chemical class 0.000 claims 2
- 230000002265 prevention Effects 0.000 claims 2
- 235000000346 sugar Nutrition 0.000 claims 2
- 150000008163 sugars Chemical class 0.000 claims 2
- 210000004369 Blood Anatomy 0.000 claims 1
- 102000016942 Elastin Human genes 0.000 claims 1
- 108010014258 Elastin Proteins 0.000 claims 1
- 210000004080 Milk Anatomy 0.000 claims 1
- 210000002826 Placenta Anatomy 0.000 claims 1
- 230000003712 anti-aging Effects 0.000 claims 1
- 239000008280 blood Substances 0.000 claims 1
- 150000001720 carbohydrates Chemical class 0.000 claims 1
- 239000003795 chemical substances by application Substances 0.000 claims 1
- 150000001875 compounds Chemical class 0.000 claims 1
- 238000000354 decomposition reaction Methods 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 229920002549 elastin Polymers 0.000 claims 1
- 230000002255 enzymatic Effects 0.000 claims 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims 1
- 238000000605 extraction Methods 0.000 claims 1
- 238000006460 hydrolysis reaction Methods 0.000 claims 1
- 230000002401 inhibitory effect Effects 0.000 claims 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N lactose group Chemical group OC1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@@H](O)[C@H](O2)CO)[C@H](O1)CO GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 claims 1
- 102000006240 membrane receptors Human genes 0.000 claims 1
- 108020004084 membrane receptors Proteins 0.000 claims 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 1
- 235000013336 milk Nutrition 0.000 claims 1
- 239000008267 milk Substances 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- 230000000069 prophylaxis Effects 0.000 claims 1
- 238000003786 synthesis reaction Methods 0.000 claims 1
- 230000000699 topical Effects 0.000 claims 1
Claims (13)
в которой n - положение 1, 2, 3, 4 или 6;
X - пентоза или гектоза при α- или β-связывании;
n' = 1 - 5.5. The use according to any one of claims 1 to 4, in which the oligosaccharide corresponds to the following formula:
in which n is position 1, 2, 3, 4 or 6;
X - pentose or hectose with α or β binding;
n '= 1 - 5.
в которой n - положение 1, 2, 3, 4 или 6;
X - пентоза или гексоза при α- или β-связывании;
n' = 1 - 5,
при условии, что если олигосахарид незамещен, он отличен от лактозы, и производное олигосахарида выбирают в одной из следующих групп: а) гликозид согласно одной из нижеуказанных формул, в которых олигосахаридом является олигозид, предпочтительно лактоза, мелибиоза или стахиоза: (I) олигозид-I-O-R, где R - линейный или разветвленный алкильный остаток с 1 - 18 атомами углерода, при условии, что если в общей формуле (А) Х - Gal и n = 1, то R отличен от этила или метила, и если олигосахаридом является лактоза, R отличен от алкильного радикала с 1 - 6 атомами углерода; (II) олигозид-I-O-R-O-I-олигозид, где R - (CH2)n; n = 2 - 10; б) ацилированный озиламин согласно одной из следующих формул, в которых олигозидом является предпочтительно лактоза, мелибиоза или стахиоза; (III) олигозид-I-NH-CO-R, где R - алкильный остаток с 2 - 18 атомами углерода, содержащий 0, 1 или 2 двойные связи; (IV) олигозид-I-NH-CO-R-CO-NH-I-олигозид, где R - (CH2)n, где n = 2 - 8; в) алкиламин, ацилированный с помощью альдоновой кислоты, получаемой путем окисления олигозида, (V) олигозид-CO-NH-R, где R имеет то же значение, что и в формуле (III); (VI) олигозид-CO-NH-R-NH-CO-олигозид, где R имеет то же значение, что и в формуле (III); г) или продукт восстановления Шиффовых оснований, образованный олигозидами с алифатическими моно- или диаминами и отвечающий формуле VII
Gal - (Hex)n-X-HN-R
или формуле VIII
Gal - (Hex)n-X-HN-R-NH-X-(Hex)n-Gal,
в которых Hex - остаток гексозы (или пентозы);
n = 0, 1 или 2;
X - остаток гекситола (или пентитола);
R имеет значение, что и в формуле (III).7. A pharmaceutical composition, characterized in that it contains, as an active principle, an oligosaccharide or an oligosaccharide derivative to which a hydrophobic radical is grafted, mixed with a pharmaceutically acceptable carrier using an oligosaccharide of the general formula A
in which n is position 1, 2, 3, 4 or 6;
X - pentose or hexose with α or β binding;
n '= 1 - 5,
provided that if the oligosaccharide is unsubstituted, it is different from lactose, and the oligosaccharide derivative is selected in one of the following groups: a) a glycoside according to one of the following formulas in which the oligosaccharide is an oligoside, preferably lactose, melibiosis or stachiosis: (I) oligoside- IOR, where R is a linear or branched alkyl residue with 1 to 18 carbon atoms, provided that if in the general formula (A) X is Gal and n = 1, then R is different from ethyl or methyl, and if the oligosaccharide is lactose, R is different from an alkyl radical with 1 to 6 carbon atoms and; (II) oligoside-IOROI-oligoside, where R is (CH 2 ) n ; n is 2-10; b) an acylated osilamine according to one of the following formulas in which the oligoside is preferably lactose, melibiosis or stachiosis; (III) oligoside-I-NH-CO-R, where R is an alkyl residue with 2 to 18 carbon atoms containing 0, 1 or 2 double bonds; (IV) oligoside-I-NH-CO-R-CO-NH-I-oligoside, where R is (CH 2 ) n , where n = 2 - 8; c) alkylamine acylated with aldonic acid obtained by oxidation of an oligoside, (V) oligoside-CO-NH-R, where R has the same meaning as in formula (III); (VI) oligoside-CO-NH-R-NH-CO-oligoside, where R has the same meaning as in formula (III); d) or a Schiff base reduction product formed by oligosides with aliphatic mono- or diamines and corresponding to formula VII
Gal - (Hex) n -X-HN-R
or formula VIII
Gal - (Hex) n -X-HN-R-NH-X- (Hex) n -Gal,
in which Hex is the residue of hexose (or pentose);
n is 0, 1 or 2;
X is the residue of hexitol (or pentitol);
R has the same meaning as in formula (III).
Gal-(Hex)n-X-HN-R
или формуле VIII
Gal-(Hex)n-X-HN-R-NH-(Hex)n-Gal;
в которых Hex - остаток гексозы (или пентозы);
n = 0, 1 или 2;
X - остаток гекситола (или пентитола);
R имеет те же значения, что и в формуле (III).9. Cosmetic composition, characterized in that it contains as an active agent that affects the aging of connective tissue, a compound selected from the group consisting of meliobiose and derivatives of oligosaccharides containing 2 to 5 ozide residues and galactose at the non-reducing end substituted by a hydrophobic radical moreover, the derivatives are selected from a) a glycoside corresponding to one of the following formulas in which the oligasaccharide is an oligoside, preferably lactose, melibiosis or stachyose: (I) oligoside-IOR, where R is ineyny or branched alkyl radical having 1 - 18 carbon atoms; (II) oligoside-IOROI-oligoside, where R is (CH 2 ) n , n = 2-10; b) acylated osilamine according to one of the following formulas in which the oligoside is preferably lactose, melibiosis or stachyose: (III) oligoside-I-NH-CO-R, where R is an alkyl residue with 2 to 18 carbon atoms containing 0, 1 or 2 double bonds; (IV) oligoside-I-NH-CO-R-CO-NH-I-oligoside, where R is (CH 2 ) n , n = 2-8; c) alkylamine acylated with aldonic acid obtained by oxidation of an oligoside, (V) oligoside-CO-NH-R, where R has the same meaning as in formula (III); (VI) oligoside-CO-NH-R-NH-CO-oligoside, where R has the same meaning as in formula (III); d) or a Schiff base reduction product formed by oligosides with aliphatic mono- or diamines and corresponding to formula (VII)
Gal- (Hex) n -X-HN-R
or formula VIII
Gal- (Hex) n -X-HN-R-NH- (Hex) n -Gal;
in which Hex is the residue of hexose (or pentose);
n is 0, 1 or 2;
X is the residue of hexitol (or pentitol);
R has the same meanings as in formula (III).
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9310054 | 1993-08-17 |
Publications (1)
Publication Number | Publication Date |
---|---|
RU96107214A true RU96107214A (en) | 1998-06-10 |
Family
ID=
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE60027455T2 (en) | OLIGOSACCHARIDEALDONIC ACID AND ITS TOPICAL ADMINISTRATION | |
CA2395121A1 (en) | Composition, in particular cosmetic or dermatological composition, containing oligosaccharides and preparation method and cosmetic treatment method | |
NZ333985A (en) | An oligosaccharide and its use in a dermatocosmetic composition | |
CH661516A5 (en) | PHENYLNONATETRAENOYL SUGAR DERIVATIVES. | |
JPH08253503A (en) | Partly n-acylated chitooligosaccharide and its salt | |
FR2886297A1 (en) | New C-glycoside compounds are tyrosinase inhibitors used in depigmenting and/or bleaching skin or hair | |
US20040022819A1 (en) | Surfactant, and an emulsion-type cosmetic composition and a liposome containing said surfactant | |
HRP940646A2 (en) | Water-soluble retinoids | |
RU96107214A (en) | APPLICATION OF OLIGOSACCHARIDES TO PREVENT OR OR TO FIGHT AGING TISSUE | |
JPWO2004033475A1 (en) | Tyrosinase activity regulator, process for producing the same, and external preparation containing the same | |
JP4039567B2 (en) | Aqueous cosmetics | |
CA1329591C (en) | Pharmaceutical products and new lactosyl compounds and the preparation thereof | |
JP3340928B2 (en) | Melanin production inhibitor and whitening cosmetic | |
JP2806033B2 (en) | Oral composition | |
JP3093016B2 (en) | Surfactant | |
JP2002516836A (en) | Use of sophorolipids containing diacetylated lactones as stimulants of skin fibroblast metabolism | |
JP2009132645A (en) | Acylated hydroquinone glucoside and skin care preparation for external use comprising the same | |
EP1051410B1 (en) | Benzo[b]pyran derivatives useful as external agents for the skin | |
AR011941A1 (en) | PHARMACEUTICAL OR COSMETIC COMPOSITION CONTAINING A COMBINATION OF AT LEAST ONE RETINOID, THE USE OF A COMBINATION OF AT LEAST ONE RETINOID FOR THE PREPARATION OF A COMPOSITION, AND THE METHOD FOR THE COSMETIC TREATMENT OF CHANGES ASSOCIATED WITH AGING OR SKIN OF THE | |
JP3340930B2 (en) | Melanin production inhibitor and whitening cosmetic | |
JP4528892B2 (en) | Soap with a whitening agent, bathing agent, fiber treatment agent, fiber | |
JP2009132644A (en) | Acne inflammation inhibitor and skin preparation for external use, containing the same | |
JPH07505871A (en) | water soluble retinoid | |
JP3976943B2 (en) | Whitening cosmetics | |
JP3435008B2 (en) | Hair restoration cosmetics |